Similar to obesity, the prevalence of MS—or comparable cardiovascular risk profiles—tends to increase with age among ALL survivors, is more common in females than males, and has been associated with prior exposure to cranial radiotherapy (CRT) and/or growth hormone (GH) abnormalities [40] (Table 2). This evidence concerns the gene GH1 and obesity due to melanocortin 4 receptor deficiency.